This is the first nationwide register-based study to examine the relationship between prenatal maternal smoking and Tourette syndrome. A total of 767 children diagnosed with Tourette syndrome were identified from the Finnish Hospital Discharge Register. Each case was matched to four controls. Information on maternal smoking during pregnancy was obtained from the Finnish Medical Birth Register. Conditional logistic regression models were used for statistical analyses. Prenatal maternal smoking was associated with Tourette syndrome when comorbid with ADHD (OR 4.0, 95 % CI 1.2-13.5, p = 0.027 for exposure during first trimester, OR 1.7, 95 % CI, 1.05-2.7, p = 0.031 for exposure for the whole pregnancy). There was no association between maternal smoking during pregnancy and Tourette syndrome without comorbid ADHD (OR 0.5, 95 % CI 0.2-1.3, p = 0.166, OR 0.9, 95 % CI 0.7-1.3, p = 0.567). Further research is needed to elucidate the mechanisms behind the association between prenatal maternal smoking and Tourette syndrome with comorbid ADHD.
Introduction
Tourette syndrome (TS) is a childhood onset neurodevelopmental disorder characterized by a combination of vocal and multiple motor tics [1] . The etiology of TS remains unclear. In addition to a likely complex genetic basis, a number of environmental factors, including pre-, peri-and postnatal adversities, may contribute to the pathogenesis of TS [2] [3] [4] although the mechanisms are still unknown. TS is often accompanied by other neurodevelopmental disorders, including ADHD, and other psychopathology [5, 6] . The prevalence of TS in children and adolescents is 0.7 % [7] .
No prevalence studies of TS have been conducted in Finland, however, the prevalence of TS seems to be similar in many countries [7] .The register-based incidences and prevalence of diagnosed TS and other tic disorders have been increasing both in Finland and other Nordic countries [8, 9] . Prevalence of attention deficit/hyperactivity disorder in an adolescent Finnish population was 8.5 % according to DSM-4 classification [10] . In a register-based data, 28 % of children diagnosed with TS specialized health care in Finland were also diagnosed with hyperkinetic disorder [8] . There are some differences between ADHD in DSM-5 and hyperkinetic disorder in ICD-10 [1, 11] . DSM-5 recognizes inattentive presentation and hyperactive-impulsive presentation when ICD-10 includes disturbance of activity and attention (F90.0), hyperkinetic conduct disorder (F90.1), other hyperkinetic disorders (F90.8) and hyperkinetic disorder unspecified (F90.9). However, the similarity between ADHD in DSM-5 and hyperkinetic disorders in ICD-10 is obvious as they recognize the same behavioral characteristics [1, 11] . We refer both hyperkinetic disorders in ICD-10 and ADHD in DSM-5 as ADHD in the following text.
Smoking is still a considerable problem among pregnant women, in Finland 15 % of women smoke during pregnancy [12] . Smoking during pregnancy has been related to neurodevelopmental disorders, including ADHD [13] [14] [15] [16] [17] [18] [19] [20] . Prenatal maternal smoking has been associated with increased tic severity [21] and comorbid ADHD or OCD [22, 23] , but the studies are few with inconsistent results [21] [22] [23] [24] [25] . The inconsistencies could be explained by relatively small sample sizes, retrospective data collection, limited consideration for confounding factors, inconsistent study populations and outcome definitions [3, 4, [21] [22] [23] [24] [25] . There is only one prospective population-based study of the association between prenatal maternal smoking and TS. The study, derived from the Avon Longitudinal Study of Parents and Children (ALSPAC) birth cohort, did not find an association between prenatal maternal smoking and onset of TS [26] .However, the sample size was limited to 50 children with TS, the children with TS with comorbid ADHD were not studied separately and the diagnoses were based on questionnaires completed by mothers [6, 26] .
The etiology of TS remains unclear, prenatal maternal smoking can be influenced by counselling, and the incidence of TS could be increasing. Thus, it is important to clarify the association between prenatal maternal smoking and TS in a large cohort. To our knowledge, the present study is the first nationwide register-based study examining the association between prenatal maternal smoking and TS. The aim of the study was to examine if prenatal maternal smoking is associated with TS. Furthermore, since TS and ADHD are highly comorbid, and there is an established association between prenatal maternal smoking and ADHD, the additional aim was to examine whether the association is different among children with TS with and without comorbid ADHD.
Methods
This study is part of the Finnish Prenatal Study of Tourette Syndrome and Other Tic Disorders (FIPS-TIC) examining pre-and perinatal risk factors for TS. FIPS-TIC is a nationwide register study based on a nested case-control design. The sampling frame included all 1199 112 children born in Finland between 1 st January 1991 and 31 st December 2010 [27] . The design was based on linking the data from three national registers: Finnish Hospital Discharge Register (FHDR), Finnish Medical Birth Register (FMBR) and Finnish Central Population Register. The cases and controls were identified from the FHDR and the Finnish Central Population Register, respectively. Linking was achieved by using personal identity codes (PIC), which are assigned to all 
National Register Information
The FHDR includes a primary diagnosis and possible subsidiary diagnoses for each patient at discharge. This information is based on clinical diagnoses. The diagnostic assessment of neurodevelopmental disorders in specialized health care in Finland is led by a child psychiatrist or pediatric neurologist. The diagnoses are given based on ICD-10 criteria. TS diagnosis is based on clinical assessment and interview accompanied with questionnaires. Psychological assessment and other differential diagnostic examinations are conducted when necessary. There is a national guideline for diagnosing and treating ADHD [28] . ADHD diagnosis is based on a comprehensive assessment including clinical assessment and interviews of the parents using structured questionnaires and collecting data from childs environment e.g. school. Cognitive capacity is examined by psychologists. When necessary, due to comorbidities and/or differential diagnostic issues, the child is examined also by other professionals e.g. speech-or occupational therapists. The FHDR was established in the 1960s and it covers all Finnish psychiatric hospitals, inpatient wards of local health care centers, military wards, prison hospitals and private hospitals since 1969 and outpatient clinics at the public hospitals since 1998. A systematic review of the quality of the FHDR showed that the accuracy of diagnosis in the register varied from satisfactory to very good as the positive predictive value (proportion of register-detected cases that were confirmed to be true positives according to the external data) varied between 75 and 99 % [29] . Furthermore, the validity of TS diagnoses in the FHDR has been studied by chart reviews and telephone interviews based on the Yale Global Tic Severity Scale and the validity of the diagnosis was shown to be 95 % [8] .
The FMBR includes standardized data on pregnancies, prenatal period and neonatal period up to 7 days of age from 1987 onwards on all births in Finland. Data on maternal smoking during pregnancy were derived from the FMBR based on information collected at maternity clinics during obstetric visits. According to THL, 99.7 % of pregnant women in Finland visit a maternity clinic. Data on smoking during pregnancy was divided into three categories: no smoking, smoking during the first trimester only, and smoking throughout the pregnancy.
The Finnish Central Population Register contains personal data about Finnish citizens and other citizens residing permanently in Finland. The data contains basic information including name, personal identity code (PIC), address, citizenship and native language, family relations, emigration and immigration dates and countries and dates of birth and death. The PIC includes date of birth, sex and a unique control number for each person. Parents of the cases and controls were identified from the Finnish Central Population Register.
The Identification of the Cases and Controls
Children diagnosed with TS (ICD-10 code F95.2 or ICD-9 code 3072D), excluding only children with severe or profound mental retardation (ICD-10 codes F72, F73 and ICD-9 codes 3181 and 3182), between 1st January 1991 and 31st December 2010 were identified from the FHDR (n = 767). The children with severe and profound mental retardation were excluded due to more difficult diagnostic evaluation of TS in these children. The most recent diagnosis was used. Children born twins (n = 24) or triplets (n = 1) were excluded to ascertain that no other factors related to these risk pregnancies influenced the results since it was unlikely to find controls fulfilling the matching criteria and requirement of twin or triplet pregnancy. Data on maternal smoking was found on 723 out of 742 remaining cases. There were 114 (15.8 %) females and 609 (84.2 %) males. The mean age of TS diagnosis was 9.5 years (standard deviation 2.8). Data on maternal socioeconomic status was found on 663 (91.7 %) cases and 103 (15.5 %) were upper white collar workers, 283 (42.7 %) were lower white collar workers, 160 (24.1 %) blue collar workers and 117 (17.7 %) others. The children with TS were stratified into two groups: TS without and with comorbid ADHD (ICD-10 codes: F90.0, F90.1, F90.8, F90.9 and ICD-9 codes: 314X).
The controls, defined as children without any tic disorder or severe or profound mental retardation, were identified from the Finnish Central Population Register. Children with other health conditions/diagnoses were not excluded. Each case was matched to four controls, on date of birth, sex and place of birth. Furthermore, those who emigrated from Finland (n = 9), who died before the case was diagnosed (n = 12), as well as the controls born from twin or triple pregnancies (n = 87), or whose case was born from twin or triplet pregnancy (n = 98) or for whom data on maternal smoking was absent (n = 68), were excluded. The number of remaining controls with data on maternal smoking was 2698.
Potential Confounding Factors
Trend of association (p \ 0.10) was tested between nine potential confounding factors associated with both prenatal maternal smoking and TS or other neurodevelopmental disorders including ADHD and autism [3, 4, 14, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] . Maternal and paternal age at time of birth were divided into four categories (\20, 20-29, 30-39, C40 years). Maternal and paternal psychiatric histories were classified dichotomously (yes/no). A parent was classified as having a psychiatric history if they had any mental disorder of F10-F99 disorder based on ICD-10 excluding mental retardation F70-F79. Corresponding diagnoses based on ICD-9 (any mental disorder 291-316, excluding organic psychiatric conditions 293-294 and 310) and ICD-8 (any mental disorder 291-308, excluding organic psychiatric conditions 292-294 (except intoxication 294.30) and conditions due to sexuality 302) were utilized during the period those diagnostic systems were in use. Maternal socioeconomic status was based on occupation during pregnancy and classified in four categories: upper white collar, lower white collar, blue collar and others. Parity was classified dichotomously 0 or C1. Birth weight and gestational age were classified as dichotomous variables: \2500 or C2500 grams and \37 weeks or C37 weeks. Apgar at 1 min was classified as 0-6 or 7-10. Data on parental age were derived from the Central Population Register, data on parental psychopathology were derived from the FHDR, and the rest of data were from the FMBR.
Statistical Analyses
Bivariate analyses were conducted to test the trend of association between potential confounding factors, described in the previous section, and maternal smoking during pregnancy among the controls as well as between potential confounding factors and TS. Conditional logistic regression analysis was used to examine the association between prenatal maternal smoking and TS. Smoking was categorized as ''no smoking'', ''smoking during the first trimester only'' and ''smoking throughout pregnancy''. First, the unadjusted odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated for the whole TS group with the limit of statistical significance of p \ 0.05. Second, the ORs were adjusted for the selected confounding factors. Finally, the unadjusted and adjusted ORs were calculated separately in data where cases were with and without co-morbid ADHD. Statistical analyses were performed with SAS statistical software (Version 9.4; SAS Institute Inc., Cary, NC).
Results
Maternal age, psychiatric history and socioeconomic status, paternal age and psychiatric history as well as birthweight and gestational age showed a trend of association (p \ 0.10) for both maternal smoking during pregnancy among the controls and TS. These covariates were included in the further analyses. Apgar score at 1 min did not show a trend of association with maternal smoking during pregnancy or TS, and therefore it was not included in the further analyses ( Table 1) .
Among the TS group, 137 (18.9 %) cases and 397 (14.7 %) controls were exposed to prenatal maternal smoking during pregnancy ( Table 2 ). The majority of the exposed cases (n = 121, 16.7 %) and controls (n = 356, 13.2 %) were exposed throughout the pregnancy. After adjusting for the confounding factors neither prenatal maternal smoking during the first trimester or throughout the pregnancy was associated with offspring TS (OR 1.1, 95 % CI 0.8-1.4 and OR 1.1, 95 % CI 0.5-2.2, respectively).
The sample was stratified into two groups: TS cases without (n = 520, 72 %) comorbid ADHD and TS cases with comorbid ADHD (n = 203, 28 %). Maternal smoking during the first trimester and throughout pregnancy was associated with TS with comorbid ADHD (OR 4.0, 95 % CI 1.2-13.5, OR 1.7, 95 % CI 1.05-2.7, respectively). However, no significant association was found between smoking during first trimester or throughout pregnancy when TS was not comorbid with ADHD (OR 0.5, 95 % CI 0.2-1.3, OR 0.9, 95 % CI 0.7-1.3, respectively).
Discussion
Our results provide evidence that maternal smoking during pregnancy has a different relationship in children with TS with, and without, comorbid ADHD. Maternal smoking during pregnancy was associated with TS with comorbid ADHD, but not with TS without ADHD. The odds ratios for TS with comorbid ADHD were higher when smoking occurred only during the first trimester compared to throughout pregnancy. However, that is likely to be explained by the small number of the children in this group leading to larger dispersion in relation to number of the cases and less accurate statistical estimation. This is supported by the more dispersed confidence interval compared with the larger group exposed throughout the pregnancy. One intriguing question is: What are the underlying mechanisms for the difference between TS with and without ADHD in relation to maternal smoking during pregnancy? The relationship between prenatal maternal smoking during pregnancy and ADHD has been established [15] [16] [17] [18] [19] [20] . However, the nature of the relationship is not fully elucidated. Nicotine has been shown to be neurotoxic in both animal and human studies [43, 44] . Animal studies have demonstrated an association between prenatal nicotine exposure and up-regulation of nicotinic acetylcholine receptors and dysregulation in several neurotransmitter systems in different regions of the brain [45] . Human studies have shown structural and functional changes in the brain associated with prenatal maternal smoking [45, 46] . As nicotine crosses the placenta during pregnancy [47] a direct intrauterine effect seems biologically plausible. However, several studies have suggested that the association between prenatal maternal smoking and ADHD is, at least partly, due to environmental or genetic confounding factors than a direct intrauterine effect [15, 20, 48] .
TS and ADHD co-occur frequently [5, 6, 8] , but the relationship between these two disorders remains unclear and debated. These disorders may share genetic factors [49] and also involve partly similar morphological changes in the brain [50] . Recent data reduction studies have identified different phenotypes of TS based on simplicity or complexity of tics, co-occurrence of ADHD and obsessivecompulsive disorder and psychopathology [51] [52] [53] . Males have been overrepresented in a phenotype having both TS/ tic disorder and ADHD [52] . Furthermore, it has been suggested that disruptive behavioral, mood and anxiety disorders may be accounted for by comorbid ADHD in children with TS [54] . TS/ADHD might reflect a separate entity rather than two co-morbid disorders [55] .
Interactions between psychosocial factors and genotype have been suggested to be involved in the etiology of ADHD [56] . Gene-environmental interactions involving prenatal maternal smoking and ADHD [57] have also been suggested, though the studies are not unequivocal [58] . Gene-environmental interactions in the etiology of TS have not been a major focus of research yet. However, Bos-Veneman et al. [24] suggested that the relationship between in utero smoking exposure and ADHD symptom severity in children with TS or chronic tic disorder was more pronounced in children with a positive family history of mental disorders. This could indicate that gene-environmental interactions affect the TS/ADHD phenotype.
The strengths of the register-based study design include large sample size, elimination of participation and re-call biases, and availability of data on several potential confounding factors. Furthermore, diagnoses were made by specialized healthcare services and the validity of the TS diagnoses in the FHDR was demonstrated to be high [8] .
Virtually, all children in Finland visit child health clinics and school health services several times during childhood and adolescence and it is likely that the children with moderate or severe TS are identified, referred to specialist clinics, and therefore, found in the FHDR. However, some of the children with mild TS may not be referred to specialized services [8] and therefore not recorded in the FHDR. Another limitation is that design of the study was based on identification of the children with TS, and therefore children with ADHD and without TS were not included into our study. Thus, we are not able to assess whether the association between prenatal maternal smoking and TS and ADHD is additive compared to ADHD only. Furthermore, since there are differences between diagnostic criteria for ADHD and hyperkinetic disorders the comparisons across different studies using different diagnostic criteria should be interpreted with caution. However, since the diagnoses are mainly overlapping and the diagnostic criteria for hyperkinetic disorder in ICD-10 are more strict than criteria for ADHD in DSM-5, the children in our study are likely to fulfill the DSM-5 criteria. In the light of the other studies, the additive model seems unlikely because in pooled analyses the estimated odds ratio for ADHD in association to prenatal maternal smoking was 2.4 [34] . Maternal smoking during pregnancy was based on self-reports which may lead to underestimation of smoking [59] . Furthermore, the register does not record the level of smoking and thus, it was not possible to assess whether the number of smoked cigarettes was of importance. Finally, information about other exposures to smoking (e.g. passive, paternal and postnatal) or other substance abuse is lacking in the register and it is impossible to assess the impact of these on the outcomes.
Summary
Prenatal maternal smoking is associated with TS when comorbid with ADHD. Since the clinical consequences of comorbid ADHD in children with TS are significant, it is of importance to inform future parents with familial loading for TS of the increased risk for comorbid TS and ADHD associated with maternal smoking during pregnancy among all the other risks related to maternal smoking. Maternal smoking should also be considered as a risk factor when assessing the comorbidities in a child with TS. The association between prenatal maternal smoking and TS with comorbid ADHD is most likely explained by the established relationship between prenatal maternal smoking and ADHD. In future studies a design including cases also with ADHD without TS is needed to substantiate this. However, in the light of recent studies indicating shared inherited factors for the different neurodevelopmental disorders further research is needed to address the intriguing question of whether the different gene-environmental interactions may explain co-occurrence and the different phenotypes of neurodevelopmental disorders. 
